{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:20:53Z","timestamp":1787836853052,"version":"build-2784847793"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ijantimicag.2023.106822","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T20:17:04Z","timestamp":1682108224000},"page":"106822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Geographic patterns of antimicrobial susceptibilities for Bacteroides spp. worldwide: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2007\u20132020"],"prefix":"10.1016","volume":"62","author":[{"given":"Pin-Han","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiu-Hsien","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Hao","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chien","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao-Wang","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Ren","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2023.106822_bib0001","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/imr.12563","article-title":"The intestinal microbiota: antibiotics, colonization resistance, and enteric pathogens","volume":"279","author":"Kim","year":"2017","journal-title":"Immunol Rev"},{"key":"10.1016\/j.ijantimicag.2023.106822_bib0002","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jmii.2019.09.009","article-title":"Trichinella spiralis infection decreases the diversity of the intestinal flora in the infected mouse","volume":"54","author":"Liu","year":"2021","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijantimicag.2023.106822_bib0003","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1128\/CMR.00008-07","article-title":"Bacteroides: the good, the bad, and the nitty-gritty","volume":"20","author":"Wexler","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2023.106822_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2020.1848158","article-title":"Gut Bacteroides species in health and disease","volume":"13","author":"Zafar","year":"2021","journal-title":"Gut Microbes"},{"key":"10.1016\/j.ijantimicag.2023.106822_bib0005","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jmii.2018.07.003","article-title":"Clinical spectrum of intra-abdominal abscesses in children admitted to the pediatric emergency department","volume":"53","author":"Chen","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijantimicag.2023.106822_bib0006","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0924-8579(02)00019-5","article-title":"New findings in beta-lactam and metronidazole resistant Bacteroides fragilis group","volume":"19","author":"Fang","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2023.106822_bib0007","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1469-0691.2010.03256.x","article-title":"ESCMID Study Group on Antimicrobial Resistance in Anaerobic Bacteria. Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience","volume":"17","author":"Nagy","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2023.106822_bib0008","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.anaerobe.2017.09.003","article-title":"Genetic identification and antimicrobial susceptibility of clinically isolated anaerobic bacteria: a prospective multicenter surveillance study in Japan","volume":"48","author":"Yunoki","year":"2017","journal-title":"Anaerobe"},{"key":"10.1016\/j.ijantimicag.2023.106822_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.anaerobe.2021.102447","article-title":"UK Bacteroides species surveillance survey: change in antimicrobial resistance over 16 years (2000\u20132016)","volume":"72","author":"Copsey-Mawer","year":"2021","journal-title":"Anaerobe"},{"key":"10.1016\/j.ijantimicag.2023.106822_bib0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.anaerobe.2016.11.003","article-title":"Trends in antimicrobial resistance among Bacteroides species and Parabacteroides species in the United States from 2010\u20132012 with comparison to 2008\u20132009","volume":"43","author":"Snydman","year":"2017","journal-title":"Anaerobe"},{"key":"10.1016\/j.ijantimicag.2023.106822_bib0011","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jmii.2018.12.009","article-title":"Evaluation of VITEK MS, Clin-ToF-II MS, Autof MS 1000 and VITEK 2 ANC card for identification of Bacteroides fragilis group isolates and antimicrobial susceptibilities of these isolates in a Chinese university hospital","volume":"52","author":"Wang","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijantimicag.2023.106822_bib0012","series-title":"Methods for antimicrobial susceptibility testing of anaerobic bacteria, M11","year":"2018"},{"key":"10.1016\/j.ijantimicag.2023.106822_bib0013","unstructured":"US Food and Drug Administration. FDA approved drug products label for Tygacil. NDA no. 021821 (approved on 23 May 2013). Silver Spring, MD: FDA. Available at: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2005\/21-821_Tygacil.cfm. 2013."},{"key":"10.1016\/j.ijantimicag.2023.106822_bib0014","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1128\/AAC.00355-08","article-title":"Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems","volume":"52","author":"Liu","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106822_bib0015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1086\/649554","article-title":"Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America","volume":"50","author":"Solomkin","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106822_bib0016","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13017-017-0141-6","article-title":"The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections","volume":"12","author":"Sartelli","year":"2017","journal-title":"World J Emerg Surg"},{"key":"10.1016\/j.ijantimicag.2023.106822_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/sur.2016.261","article-title":"The Surgical Infection Society revised guidelines on the management of intra-abdominal infection","volume":"18","author":"Mazuski","year":"2017","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.ijantimicag.2023.106822_bib0018","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3947\/ic.2022.0156","article-title":"Korean guidelines for use of antibiotics for intra-abdominal infections in adults","volume":"54","author":"Yoon","year":"2022","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106822_bib0019","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13613-020-00715-2","article-title":"Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections","volume":"10","author":"Pascale","year":"2020","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.ijantimicag.2023.106822_bib0020","doi-asserted-by":"crossref","first-page":"e12467","DOI":"10.1097\/MD.0000000000012467","article-title":"Adverse events of high-dose tigecycline in the treatment of ventilator-associated pneumonia due to multidrug-resistant pathogens","volume":"97","author":"Chen","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijantimicag.2023.106822_bib0021","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1089\/mdr.2019.0462","article-title":"Trends and impact in antimicrobial resistance among Bacteroides and Parabacteroides species in 2007\u20132012 compared to 2013\u20132017","volume":"26","author":"Kierzkowska","year":"2020","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ijantimicag.2023.106822_bib0023","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jgar.2021.01.007","article-title":"Diversity of antimicrobial resistance genes in Bacteroides and Parabacteroides strains isolated in Germany","volume":"24","author":"Rong","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijantimicag.2023.106822_bib0024","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1128\/CMR.00086-12","article-title":"Antianaerobic antimicrobials: spectrum and susceptibility testing","volume":"26","author":"Brook","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2023.106822_bib0025","first-page":"28","article-title":"Prevalence of antimicrobial resistant genes in Bacteroides spp. isolated in Oita Prefecture","volume":"29","author":"Hashimoto","year":"2023","journal-title":"Japan. J Infect Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106822_bib0026","doi-asserted-by":"crossref","first-page":"6393","DOI":"10.1128\/AAC.01125-16","article-title":"in vitro evaluation of the activity of imipenem-relebactam against 451 recent clinical isolates of Bacteroides group and related species","volume":"60","author":"Snydman","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106822_bib0027","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.02188-21","article-title":"Development and validation of a novel anaerobic carbapenem inactivation method (Ana-CIM) for the detection of carbapenemase production in Bacteroides fragilis","volume":"60","author":"Eberly","year":"2022","journal-title":"J Clin Microbiol"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857923001012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857923001012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:45:45Z","timestamp":1760377545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857923001012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0924857923001012"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106822","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Geographic patterns of antimicrobial susceptibilities for Bacteroides spp. worldwide: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2007\u20132020","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106822","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106822"}}